P57.02 Integration of Systemic / Tumor PD-L1 as a Predictive Biomarker of Clinical Outcome in Advanced NSCLC Patients Treated With Anti-PD-(L)1 Agents

Autor: Anguera Palacios, G., Zamora Atenza, C., Riudavets Melià, M., Alserawan De Lamo, L., Sullivan, I., Barba Joaquín, A., Serra Lopez, J., Ortiz, M.A., Mulet, M., Vidal Alcorisa, S., Majem, M.
Zdroj: In Journal of Thoracic Oncology October 2021 16(10) Supplement:S1136-S1137
Databáze: ScienceDirect